Arcturus Therapeutics Holdings Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Development Agreements (4)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Supply Agreements (1)
- Termination Agreements (1)
- Amendment Number Two to Collaboration and License Agreement, dated March 29, 2024, by and between Arcturus Therapeutics, Inc. and Seqirus Inc (Filed With SEC on May 8, 2024)
- Amendment Number One to Collaboration and License Agreement, dated August 3, 2023, by and between Arcturus Therapeutics, Inc. and Seqirus Inc (Filed With SEC on November 14, 2023)
- Amendment No. 1 to Controlled Equity Offering Sales Agreement (Filed With SEC on August 7, 2023)
- Manufacturing Support Agreement, dated November 7, 2020, between Arcturus Therapeutics Holdings, Inc. and the Economic Development Board of Singapore (Filed With SEC on November 9, 2020)
- Supply Agreement, dated August 17, 2020, between Arcturus Therapeutics, Inc. and the Israeli Ministry of Health (Filed With SEC on November 9, 2020)
- Sales Agreement, dated as of March 27, 2020, between the Company and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 27, 2020)
- Acceptance Letter, dated March 4, 2020, between Arcturus Therapeutics Holdings Inc. and the Economic Development Board of Singapore (Filed With SEC on March 16, 2020)
- Form of Indemnification Agreement (Filed With SEC on March 16, 2020)
- Termination Agreement, dated July 26, 2019, by and between Arcturus Therapeutics, Inc. and CureVac AG (Filed With SEC on August 14, 2019)
- Amendment to Development and Option Agreement, dated July 26, 2019, by and between Arcturus Therapeutics, Inc. and CureVac AG (Filed With SEC on August 14, 2019)
- Amendment dated as of August 1, 2019, by and between Arcturus Therapeutics, Inc. and Cystic Fibrosis Foundation to that certain Development Program Letter Agreement of May 16, 2017 (Filed With SEC on August 14, 2019)
- Third Amendment, dated June 18, 2019 to Research Collaboration and License Agreement, dated October 26, 2015, as amended on October 17, 2017 and April 20, 2018, between the... (Filed With SEC on June 20, 2019)
